Cited 8 times in
Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강은석 | - |
dc.contributor.author | 김규리 | - |
dc.contributor.author | 남정모 | - |
dc.contributor.author | 이병완 | - |
dc.contributor.author | 이용호 | - |
dc.contributor.author | 이지연 | - |
dc.contributor.author | 차봉수 | - |
dc.date.accessioned | 2019-09-20T07:32:58Z | - |
dc.date.available | 2019-09-20T07:32:58Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1262-3636 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/170945 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English, French | - |
dc.publisher | Masson | - |
dc.relation.isPartOf | Diabetes & Metabolism | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Carcinoma, Hepatocellular/epidemiology | - |
dc.subject.MESH | Carcinoma, Hepatocellular/etiology* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Gliclazide/adverse effects* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypoglycemic Agents/adverse effects* | - |
dc.subject.MESH | Incidence | - |
dc.subject.MESH | Liver Neoplasms/epidemiology | - |
dc.subject.MESH | Liver Neoplasms/etiology* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Risk | - |
dc.subject.MESH | Sulfonylurea Compounds/adverse effects* | - |
dc.title | Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | J.-Y. Lee | - |
dc.contributor.googleauthor | G. Kim | - |
dc.contributor.googleauthor | Y.-H. Lee | - |
dc.contributor.googleauthor | B.-W. Lee | - |
dc.contributor.googleauthor | B.-S. Cha | - |
dc.contributor.googleauthor | C.M. Nam | - |
dc.contributor.googleauthor | E.S. Kang | - |
dc.identifier.doi | 10.1016/j.diabet.2017.06.007 | - |
dc.contributor.localId | A00068 | - |
dc.contributor.localId | A00322 | - |
dc.contributor.localId | A01264 | - |
dc.contributor.localId | A02796 | - |
dc.contributor.localId | A02989 | - |
dc.contributor.localId | A03197 | - |
dc.contributor.localId | A03996 | - |
dc.relation.journalcode | J00719 | - |
dc.identifier.eissn | 1878-1780 | - |
dc.identifier.pmid | 28778564 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1262363617304718 | - |
dc.contributor.alternativeName | Kang, Eun Seok | - |
dc.contributor.affiliatedAuthor | 강은석 | - |
dc.contributor.affiliatedAuthor | 김규리 | - |
dc.contributor.affiliatedAuthor | 남정모 | - |
dc.contributor.affiliatedAuthor | 이병완 | - |
dc.contributor.affiliatedAuthor | 이용호 | - |
dc.contributor.affiliatedAuthor | 이지연 | - |
dc.contributor.affiliatedAuthor | 차봉수 | - |
dc.citation.volume | 45 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 83 | - |
dc.citation.endPage | 85 | - |
dc.identifier.bibliographicCitation | Diabetes & Metabolism, Vol.45(1) : 83-85, 2019 | - |
dc.identifier.rimsid | 64358 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.